National IV fluids supply threatened by hurricanes
Hurricane Helene shut down a top manufacturer of IV solutions in the U.S., threatening hospitals across the country with shortages. Milton’s landfall this week could make the problem even worse.
Baxter International’s manufacturing plant in Marion, N.C., supplied roughly 60 percent of the IV solutions used by hospitals in the U.S. before Helene shut down production.
The company says it expects the plant will reopen sometime in the next two weeks, but full productivity might not be returned until the end of this year.
“Our goal is to restart North Cove production in phases and return to 90% to 100% allocation of certain IV solution product codes by the end of 2024,” Baxter said in its most recent update on the situation.
There are other domestic producers of IV fluids, but Milton’s approach threatens another top manufacturer, B. Braun. The company has an IV manufacturing facility in Dayton Beach, Fla., close to Milton’s expected path.
According to the American Hospital Association (AHA), hospitals in the U.S. have been told to expect 40 percent of their normal shipments of IV solution.
As health care providers grapple with a likely shortage of these crucial medical products, industry groups and federal authorities have turned to several potential measures to mitigate the problem:
Declare a shortage of IV solutions: The AHA has called on the federal government to declare a shortage so hospitals will have the flexibility to prepare IV solutions in their own pharmacies and so providers know to conserve their supply.
Move existing supply: In anticipation of Milton, B. Braun and the federal Administration for Strategic Preparedness and Response confirmed that the Dayton Beach facility has been temporarily shut down, and the supply of IV solutions at the company’s distribution center has been relocated.
Relax regulations: Industry groups like the American Society of Health-System Pharmacists have called for temporary flexibilities in inspection requirements, limits on compounding IV solutions and expiration dates.
Expedite imports: According to one senior administration official, the Food and Drug Administration is considering temporary imports and expedited reviews of restored manufacturing lines.
Gets others to step in: With a major supplier temporarily out of commission, stakeholders are looking to other manufacturers to ramp up production. A spokesperson for B. Braun said the company is increasing production at its Irvine, Calif., plant. Another major producer of IV solutions, ICU Medical with a facility in Austin, Texas, said it too has taken steps to ramp up production.
Welcome to The Hill’s Health Care newsletter, we’re Nathaniel Weixel, Joseph Choi and Alejandra O’Connell-Domenech — every week we follow the latest moves on how Washington impacts your health.
Did someone forward you this newsletter? Subscribe here.
Essential Reads
How policy will be impacting the health care sector this week and beyond:
COVID-19 may increase risk of death years after infection: Study
COVID-19 could increase the risk of major cardiac events, like strokes and heart attacks, according to a study from the Keck School of Medicine of University of Southern California; the University of California, Los Angeles; and Cleveland Clinic released Wednesday. The findings revealed individuals with A, B and AB blood types that contracted a severe version of COVID-19 are more likely to have future heart problems than people …
Full Story
CVS, UnitedHealth press for FTC Chair Khan to be removed from PBM lawsuit
UnitedHealth and CVS Caremark are calling on a federal judge to disqualify Federal Trade Commission (FTC) Chair Lina Khan and two other commissioners from the agency’s lawsuit against the country’s largest pharmacy benefit managers (PBMs). Attorneys for UnitedHealth’s Optum Rx and CVS Caremark said Khan, along with Commissioners Alvaro Bedoya and Rebecca Kelly Slaughter, have long track records of publicly maligning PBMs …
Full Story
46 percent in Florida poll say they will vote for abortion rights amendment
Less than half of the likely electorate in Florida say they would vote for an amendment that would legalize abortion up to the point of fetal viability, according to a New York Times and Siena College poll published Tuesday. The survey, conducted from Sept. 29 to Oct. 6, found that among likely voters in the state, 46 percent said they would vote for Amendment 4, which would legalize abortions up to what is about the 24th week …
Full Story
Around the Nation
Local and state headlines on health care:
Florida healthcare workers exhausted as Hurricane Milton approaches (The Washington Post)
Mental health support for toddlers has lagged in Texas. That’s now changing (The Texas Tribune)
Hospitals in Brooklyn facing maternal health crisis, health department says (CBS)
What We’re Reading
Health news we’ve flagged from other outlets:
Medical facilities in Milton’s path are preparing with closures and barricades (The New York Times)
Employers may start covering weight loss drugs soon (CNN)
Employers haven’t a clue how their drug benefits are managed (KFF News)
What Others are Reading
Most read stories on The Hill right now:
Democrats start to hit the panic button
Democrats’ nerves are at an all-time high. Two months ago — even a month ago — they were feeling bullish about Vice President Harris’s … Read more
Susan Rice: Trump’s reported calls with Putin appear illegal
Former White House adviser and United Nations ambassador Susan Rice called out former President Trump over a report that he has spoken with Russian … Read more
What People Think
Opinions related to health submitted to The Hill:
Fentanyl is still a crisis, and securing the border is not enough
Getting old is inevitable. Getting sick is not.
You’re all caught up. See you tomorrow!
Close
Thank you for signing up!
Subscribe to more newsletters here
The latest in politics and policy.
Direct to your inbox.
Sign up for the Health Care newsletter
if ( window.checkSizeClasses && window.checkSizeClasses instanceof Function) {
window.checkSizeClasses();
}
